Rheinmetall's Q1 Cash Squeeze and Dual Analyst Downgrades: A Test of the Order Book's Promise

Defence giant Rheinmetall faces investor skepticism as Q1 negative free cash flow of €285M overshadows a record €73B order backlog, despite strong revenue coverage and analyst Buy ratings.

Rheinmetall is a study in contrasts. The defence contractor's order backlog sits at a record €73 billion, yet its stock has shed nearly a quarter of its value this year. The root of the tension: a negative free cash flow of €285 million in the first quarter that has investors questioning whether the company can convert its bumper order book into hard cash at the promised pace.

Management is fighting back. Over the past week, Rheinmetall has taken its pitch to the Berenberg European Conference in New York and the Barclays European Leadership Conference in London. The message to investors is that operational momentum is stronger than the share price suggests. Around 97% of the full-year revenue target — set at €14 billion to €14.5 billion — is already covered by existing orders. The company expects organic top-line growth of 28% to 31% in 2026 and an operating margin of roughly 19%.

Yet the stock remains under pressure. On Friday, shares closed at €1,221.40, a gain of just 0.41%. That leaves the price 9.25% above the 52-week low of €1,118 hit on May 13, but still 38.78% below the year's peak of €1,995. The year-to-date loss stands at 23.73%, and over twelve months the decline has widened to 31.50%.

The cash flow deficit is the central sore point. Management blames the negative operating free cash flow of minus €285 million on inventory build-up and tied-up working capital, both intended to support the planned growth ramp. But the market is demanding evidence that orders are translating into deliveries and, ultimately, cash. Delays on certain shipments have only stoked those doubts.

Adding to the narrative, analysts have moved to trim their expectations — though they stopped short of turning bearish. Within 48 hours, three analysts delivered revisions. Jefferies cut its price target from €2,220 to €1,890, citing rising execution risks, while maintaining a "Buy" rating. Analyst Chloe Lemarie dismissed concerns about the underlying product relevance as overblown. More sharply, UBS's Sven Weier slashed his target by over 27% to €1,600, arguing the market underestimates the growth potential in the ammunition business and the success of the Boxer armoured vehicle. He too kept a "Buy" rating. Barclays stood pat with an "Overweight" recommendation and a €2,035 target.

The revised targets — ranging from €1,600 to €2,035 — all sit comfortably above the current market price, underscoring a gap between near-term caution and long-term conviction.

Two other developments are adding layers of uncertainty. Rheinmetall is reportedly interested in acquiring the military division of Italian manufacturer Iveco, a move that would strengthen its footprint in European land defence systems. With €73 billion in orders, the financial firepower is there, but any deal would add integration risk. Meanwhile, a ruling by the Higher Regional Court of Düsseldorf has declared parts of Germany's law to accelerate defence procurement unconstitutional. The case now goes to the Federal Constitutional Court, and an adverse final decision could disrupt planning certainty for large-scale projects.

On the shareholder front, US asset manager FMR LLC has dropped below the 3% voting rights threshold, now holding 2.88%. While such moves carry limited explanatory power in isolation, they add to the narrative of institutional repositioning during a volatile period.

Technically, the stock shows mixed signals. The relative strength index stands at 85.6, pointing to a short-term overbought condition after a modest recovery from the low. The distance to the 200-day moving average is 25.73%, confirming the longer-term downtrend remains intact.

Rheinmetall's next major test comes on August 6, 2026, when it reports second-quarter results. Cash flow progress and delivery milestones will be in sharp focus, and investors will see whether the management roadshow has done more than polish the message. Until then, the company must convince the market that its record backlog is not just a headline number — but a pipeline that delivers.